{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:44:33Z","timestamp":1771998273855,"version":"3.50.1"},"reference-count":20,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s427809","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T05:00:12Z","timestamp":1696309212000},"page":"2451-2461","source":"Crossref","is-referenced-by-count":3,"title":["Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Alan","family":"Kivitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishvesh","family":"Shende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-1492","authenticated-orcid":true,"given":"J\u00e9r\u00e9my","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daljit","family":"Tatla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.36849\/JDD.6274","volume":"21","author":"Bagel","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(21)00126-4","volume":"397","author":"Gordon","year":"2021","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jamadermatol.2021.2905","volume":"157","author":"Glatt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/ard-2022-223595","volume":"82","author":"Van der Heijde","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0140-6736(22)02303-0","volume":"401","author":"Merola","year":"2023","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0140-6736(22)02302-9","volume":"401","author":"McInnes","year":"2023","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0140-6736(21)00125-2","volume":"397","author":"Reich","year":"2021","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa2102388","volume":"385","author":"Warren","year":"2021","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1517\/14712590903530633","volume":"10","author":"Borr\u00e1s-Blasco","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1517\/14712598.2013.795942","volume":"13","author":"Borr\u00e1s-Blasco","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/DHPS.S290771","volume":"13","author":"Tornero Molina","year":"2021","journal-title":"Drug Healthc Patient Saf"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"Coates","year":"2017","journal-title":"Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","volume":"74","author":"Mease","year":"2014","journal-title":"Drugs"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/s-0032-1321760","volume":"44","author":"Jevtic","year":"2012","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/1756-185X.14241","volume":"25","author":"Candiri","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1477-7525-9-2","volume":"9","author":"Keininger","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"ref18","unstructured":"UCB Biopharma SRL. A study to assess the long-term safety, tolerability, and efficacy of bimekizumab in the treatment of subjects with active psoriatic arthritis (BE VITAL). NLM identifier: NCT04009499. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04009499. Accessed June 21, 2023."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1002\/acr.20345","volume":"63","author":"Hawker","year":"2011","journal-title":"Arthritis Care Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1515\/jpem-2017-0146","volume":"30","author":"Gau","year":"2017","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=93235","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=93235","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T05:00:16Z","timestamp":1696309216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/safe-and-effective-subcutaneous-self-injection-of-bimekizumab-with-saf-peer-reviewed-fulltext-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2147\/ppa.s427809","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}